Journey Medical Corp (DERM) Deferred Tax Assets, Valuation Allowance USD 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Journey Medical Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2021 to 2023.
  • Journey Medical Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $20.2 M, a 4.39% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $20.2 M +$847 K +4.39% Dec 31, 2023 10-K 2024-03-29
Q4 2022 $19.3 M +$8.44 M +77.6% Dec 31, 2022 10-K 2024-03-29
Q4 2021 $10.9 M Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.